Natural Gums as Superdisintegrant in Fast Dissolving Tablets: Mechanistic Insights, Comparative Evaluation and Future Perspectives

Abstract

Fast dissolving tablets (FDTs) are solid oral dosage forms designed to disintegrate rapidly in the oral cavity without the need for water, thereby enhancing patient compliance, especially in pediatric, geriatric, and dysphagic populations. The performance of FDTs is largely governed by the efficiency of superdisintegrants incorporated into the formulation. Although synthetic superdisintegrants such as croscarmellose sodium, crospovidone, and sodium starch glycolate are widely employed, growing interest in sustainability, biocompatibility, and cost-effectiveness has directed attention toward natural gums derived from plant sources. Natural polysaccharides including guar gum, xanthan gum, locust bean gum, fenugreek mucilage, okra mucilage, and Plantago ovata mucilage exhibit intrinsic swelling, hydration, and wicking properties suitable for rapid tablet disintegration. This review critically examines the physicochemical characteristics, disintegration mechanisms, structure function relationships, modification strategies, comparative performance with synthetic agents, safety considerations, and regulatory aspects of natural gums used in FDT formulations. Emphasis is placed on mechanistic understanding, swelling kinetics, excipient drug compatibility, and formulation optimization. The review also highlights current limitations and future research directions aimed at enhancing the performance consistency and industrial applicability of natural superdisintegrants.

Keywords

Introduction

4. Comparative Performance with Synthetic Superdisintegrants

Comparative investigations have demonstrated that natural gums, when optimized in formulation, can achieve rapid disintegration times in the range of 20–40 seconds, which is comparable to many conventional superdisintegrants used in fast dissolving tablets (FDTs)¹¹. In contrast, synthetic superdisintegrants such as croscarmellose sodium, crospovidone, and sodium starch glycolate generally produce slightly faster disintegration times of 15–30 seconds and are often effective at lower concentrations¹³. Nevertheless, natural gums present several significant advantages, including excellent biodegradability, minimal toxicity, cost effectiveness, and availability from renewable plant or microbial sources, making them environmentally sustainable alternatives. Their natural origin also enhances patient acceptability and supports the growing demand for green pharmaceutical excipients. However, certain limitations must be considered, such as the need for relatively higher concentrations to achieve comparable performance and their sensitivity to moisture, which may affect stability and flow properties. Therefore, while synthetic agents may offer greater efficiency at lower levels, natural gums represent a promising, eco-friendly option for FDT formulations when appropriately optimized.

Table 2. Comparative Evaluation

5. Modification and Co-Processing Approaches

Chemical modification and co-processing techniques are commonly utilized to improve the functional performance of excipients used as superdisintegrants in fast dissolving tablets (FDTs). Modifications such as crosslinking and carboxymethylation notably enhance the water absorption, swelling capacity, and disintegration effectiveness of natural polymers. Crosslinking minimizes excessive solubility while facilitating quick hydration and controlled swelling, whereas carboxymethylation adds hydrophilic carboxymethyl groups that boost water penetration and swelling kinetics, resulting in faster tablet disintegration^14,15. Alongside chemical modification, co-processing methods that involve merging two or more excipients at the sub-particle level are employed to synergistically enhance physicomechanical properties without changing the chemical structure. Chemical modification such as crosslinking or carboxymethylation improves swelling kinetics¹². Co-processing with microcrystalline cellulose enhances compressibility³. For example, combining natural polymers with microcrystalline cellulose (MCC) improves compressibility, flow characteristics, and tablet hardness while still allowing for quick disintegration because of MCC’s superior binding and wicking properties¹⁶. Therefore, both chemical alterations and co-processing are viable strategies to enhance excipient functionality, leading to better swelling behavior, mechanical strength, and overall efficacy of fast-dissolving tablet (FDT) formulations.

6. Drug–Excipient Compatibility

Compatibility studies between drugs and excipients are crucial for ensuring the stability, effectiveness, and safety of pharmaceutical formulations, especially in fast dissolving tablets that use natural gums as superdisintegrants. Analytical methods like differential scanning calorimetry (DSC), Fourier transform infrared spectroscopy (FTIR), and X-ray diffraction (XRD) are commonly used to assess possible physicochemical interactions between the drug and excipients. DSC is useful for identifying changes in melting endotherms or thermal properties, while FTIR detects potential chemical interactions by noting shifts or the loss of specific functional group peaks. XRD is employed to examine changes in crystallinity patterns. Compatibility studies using DSC, FTIR, and XRD confirm minimal chemical interaction between natural gums and most APIs¹. However, hygroscopicity may influence stability. Numerous studies have indicated that natural gums, including guar gum, xanthan gum, and gum karaya, typically demonstrate minimal chemical interactions with most active pharmaceutical ingredients (APIs), suggesting good compatibility and appropriateness for solid dosage forms¹⁷. Nevertheless, because of their hydrophilic and frequently hygroscopic characteristics, natural gums can take up moisture from the atmosphere, potentially impacting drug stability, leading to hydrolytic degradation, or altering tablet hardness and disintegration properties. Consequently, it is advisable to conduct suitable stability studies and utilize moisture-resistant packaging to guarantee the long term stability of the formulation.

7. Safety and Regulatory Considerations

Many natural gums are widely used in food and pharmaceutical applications and are considered safe⁷. Nevertheless, microbial limits and quality control are critical. Natural gums are widely used in food and pharmaceutical products because of their compatibility with biological systems, ability to decompose naturally, and safety profiles that are commonly accepted. Various polymers like guar gum, xanthan gum, acacia, and locust bean gum are categorized as Generally Recognized as Safe (GRAS) substances and are included in prominent pharmacopeias, which supports their use as pharmaceutical excipients^14,18. Their long-standing history of safe human consumption and minimal toxicity make them appealing alternatives to synthetic excipients in solid dosage forms, such as fast-dissolving tablets. However, since these natural gums are sourced from plants or microbes, they may face issues such as variability between batches, risk of microbial contamination, pesticide residues, and possible endotoxin presence. Consequently, it is crucial to rigorously follow pharmacopeial standards, conduct microbial limit tests, and implement good manufacturing practices (GMP) to guarantee the safety, purity, and quality of products¹⁹. Thorough quality control protocols, such as measuring moisture content and evaluating microbial load, play a vital role in ensuring formulation stability and adhering to regulatory requirements.

8. Challenges

Although natural gums have many benefits, they also pose several formulation and manufacturing difficulties. Because they are obtained from plant or microbial sources, they are inherently at risk for microbial contamination, which requires thorough microbial limit testing and suitable storage conditions to guarantee safety and adherence to regulations. Their hydrophilic characteristics make them very sensitive to moisture; excessive moisture absorption can hinder powder flow, encourage degradation of drugs (especially those prone to hydrolysis), and negatively impact tablet hardness and disintegration time. Furthermore, natural gums frequently display variability from batch to batch due to variations in geographical origin, harvesting conditions, and purification methods, which can result in inconsistencies in viscosity, swelling properties, and overall efficacy. Additionally, certain natural gums have restricted mechanical strength and inadequate compressibility, leading to tablets that may exhibit reduced hardness or increased friability unless they are modified or combined with appropriate excipients. As a result, meticulous quality control, optimization techniques, and suitable formulation design are crucial to address these challenges and guarantee reliable product performance.

9. Future Perspectives

The future evolution of natural gums as pharmaceutical excipients is anticipated to emphasize innovative modification techniques and sustainable design methods. Nanostructured gums, created through approaches like nanoparticle formation, nano-crosslinking, or surface functionalization, present increased surface area, enhanced swelling kinetics, and better control over drug release, making them attractive candidates for advanced fast-dissolving and controlled-release formulations. The surge in developing co-processed hybrid excipients that blend natural gums with synthetic or multifunctional materials is noteworthy, as these combinations can jointly enhance compressibility, flow characteristics, mechanical strength, and disintegration efficiency. Additionally, cutting-edge characterization methods such as scanning electron microscopy (SEM) and rheological analysis offer greater understanding of surface structure, particle architecture, swelling behavior, and viscoelastic properties, facilitating more accurate structure-function relationships. Significantly, the increasing focus on green chemistry and sustainability is leading to the investigation of renewable, biodegradable, and low-carbon-footprint excipients, making natural gums essential elements in creating environmentally friendly pharmaceutical formulations.

CONCLUSION

To conclusion, natural gums are turning out to be effective and sustainable substitutes for synthetic superdisintegrants in the creation of fast dissolving tablets (FDTs). Thanks to their natural properties of swelling, hydration, and wicking, plant derived polysaccharides like guar gum, xanthan gum, fenugreek mucilage, and Plantago ovata mucilage can significantly enhance rapid tablet disintegration while ensuring safety, biodegradability, and cost-effectiveness. Despite synthetic superdisintegrants typically providing slightly quicker disintegration at lower amounts, well-optimized natural gums have demonstrated similar efficacy when properly processed and formulated. Their renewable source, acceptance by regulatory bodies, and low toxicity further enhance their appeal in both industrial and environmental contexts. Nonetheless, issues such as variability between batches, sensitivity to moisture, risk of microbial contamination, and limitations in mechanical strength need careful attention through modification methods, co-processing techniques, and rigorous quality control. Future advancement in nanostructuring, the creation of hybrid excipients, and sophisticated physicochemical analysis is likely to improve the reliability, scalability, and market potential of natural gums. In summary, ongoing research and technological advancements could significantly transform sustainable excipient development within modern pharmaceutical formulation science.

REFERENCES

1. Allen L, Ansel HC. Ansel's pharmaceutical dosage forms and drug delivery systems. Lippincott Williams & Wilkins; 2013 Dec 23.
2. Fu Y, Yang S, Jeong SH, Kimura S, Park K. Orally fast disintegrating tablets: developments, technologies, taste-masking and clinical studies. Critical Reviews™ in Therapeutic Drug Carrier Systems. 2004;21(6).
3. Gohel MC, Parikh RK, Brahmbhatt BK, Shah AR. Improving the tablet characteristics and dissolution profile of ibuprofen by using a novel coprocessed superdisintegrant: a technical note. AAPS PharmSciTech. 2007 Mar;8(1):13.
4. Lowenthal W. Mechanism of action of tablet disintegrants. Pharmaceutica Acta Helvetiae. 1973 Nov-Dec;48(11):589-609. PMID: 4593513.
5. Saha D, Bhattacharya S. Hydrocolloids as thickening and gelling agents in food: a critical review. Journal of food science and technology. 2010 Dec;47(6):587-97.
6. Desai PM, Liew CV, Heng PW. Review of disintegrants and the disintegration phenomena. Journal of pharmaceutical sciences. 2016 Sep 1;105(9):2545-55.
7. Shirwaikar A, Shirwaikar A, Prabu SL, Kumar GA. Herbal excipients in novel drug delivery systems. Indian journal of pharmaceutical sciences. 2008 Jul;70(4):415.
8. Madhulika GS, Kuber B. A review on natural and synthetic polymers employed in the formulation of oral disintegrating tablets. J Drug Deliv Ther. 2019 Mar 2;9.
9. Prajapati VD, Jani GK, Moradiya NG, Randeria NP. Pharmaceutical applications of various natural gums, mucilages and their modified forms. Carbohydrate polymers. 2013 Feb 15;92(2):1685-99.
10. Shirsand SB, Suresh S, Para MS, Swamy PV, Kumar DN. Plantago ovata mucilage in the design of fast disintegrating tablets. Indian Journal of Pharmaceutical Sciences. 2009 Jan;71(1):41.
11. Yadav, Nikku D., Prashant L. Pingale, and Sagar R. Tatane. "Comparative study on effect of natural and artificial superdisintegrants in the formulation of fast dissolving aspirin tablet." (2010): 1594-1597.
12. Zhang, Y., Law, Y., & Chakrabarti, S. (2003). Physical properties and compact analysis of commonly used direct compression binders. AAPS PharmSciTech, 4(4), E62. https://doi.org/10.1208/pt040462
13. Zhao N, Augsburger LL. The influence of swelling capacity of superdisintegrants in different pH media on the dissolution of hydrochlorothiazide from directly compressed tablets. AAPS pharmscitech. 2005 Mar;6(1):19.
14. Rowe RC, Sheskey PJ, Quinn ME, editors. Handbook of pharmaceutical excipients. London: Pharmaceutical press; 2006 Jan 30.
15. Rathore D, Jain DV, Gehalot N. Formulation and Evaluation of Fast Dissolving Tablets of Aceclofenac Using Natural Superdisintegrant. International Journal of Pharmaceutical Sciences & Medicine. 2022;7(10):39-64.
16. Gohel MC, Jogani PD. A review of co-processed directly compressible excipients. J Pharm Pharm Sci. 2005 Apr 16;8(1):76-93.
17. Aulton ME, Taylor K, editors. Aulton's pharmaceutics: the design and manufacture of medicines. Elsevier Health Sciences; 2013.
18. FAO/WHO Joint Expert Committee on Food Additives (JECFA). Safety evaluation of certain food additives. WHO Press; 2017.
19. United States Pharmacopeia (USP) 46–NF 41. Rockville, MD: United States Pharmacopeial Convention; 2023.